Excursions out-of-lane versus standard deviation of lateral position as outcome measure of the on-the-road driving test

Human Psychopharmacology

Volumn 29, Issue 4, 2014, Pages 322-329

  Verster, Joris C ^a,b   Roth, Thomas ^c  

^a UTRECHT UNIVERSITY   (Netherlands)

^b SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^c HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

driving; excursions out of lane; impairment; on road; SDLP

Indexed keywords

FLUNITRAZEPAM; FLURAZEPAM; HYPNOTIC AGENT; LOPRAZOLAM; LORMETAZEPAM; NITRAZEPAM; OXAZEPAM; RAMELTEON; SECOBARBITAL; ZALEPLON; ZOLPIDEM; ZOPICLONE; HYPNOTIC SEDATIVE AGENT;

ARTICLE; CAR DRIVING; DRIVER; DRIVING ABILITY; EXCURSION OUT OF LANE; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEDATION; STANDARD DEVIATION OF LATERAL POSITION; TRAFFIC; DRUG EFFECTS; NEUROPSYCHOLOGICAL TEST; PSYCHOMOTOR PERFORMANCE;

AUTOMOBILE DRIVING; HUMANS; HYPNOTICS AND SEDATIVES; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE;

EID: 84904039626     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.2406     Document Type: Article

References (18)

1. Louwerens JW, Gloerich ABM, De Vries G, Brookhuis KA, O'Hanlon JF,. 1987. The relationship between drivers' blood alcohol concentration (BAC) and actual driving performance during high speed travel. In Alcohol, Drugs and Traffic Safety, Noordzij PC, Roszbach R, (eds). Excerpta Medica: Amsterdam; 183-192.
2. Mets MAJ, de Vries JM, de Senerpont Domis LM, et al,. 2011. Next-day effects of ramelteon (8 mg), zopiclone (7.5 mg), and placebo on highway driving performance, memory functioning, psychomotor performance and mood in healthy adult subjects. Sleep 34: 1327-1334.
3. O'Hanlon JF, Volkerts ER,. 1986. Hypnotics and actual driving performance. Acta Psychiatrica 74: 95-104.
4. O'Hanlon JF, Haak TW, Blauw GJ, Riemersma JBJ,. 1982. Diazepam impairs lateral position control in highway driving. Science 217: 79-81.
5. Owens K, Ramaekers JG,. 2009. Drugs, driving, and models to measure driving impairment. In Drugs, Driving and Traffic Safety, Verster JC, Pandi-Perumal SR, Ramaekers JG, de Gier JJ, (eds). Birkhauser Verlag AG: Basel, Switzerland; 43-58.
6. Penning R, Veldstra J, Daamen AP, Olivier B, Verster JC,. 2010. Drugs of abuse, driving and traffic safety. Curr Drug Abuse Rev 3: 23-32.
7. Verster JC, Mets MAJ,. 2009. Psychoactive medication and traffic safety. Int J Environ Res Public Health 6: 1041-1054.
8. Verster JC, Roth T,. 2011. Standard Operation Procedures for conducting the on-the-road driving test, and measurement of the standard deviation of lateral position (SDLP). Int J Gen Med 4: 359-371.
9. Verster JC, Roth T,. 2012. Thirty years of dutch drugs and driving research: strengths and limitations of the on-the-road highway driving test and future challenges. Curr Psychopharmacol 1: 97-102.
10. Verster JC, Roth T,. 2014. Effects of CNS drugs on driving: speed variability versus SDLP as outcome measure of the on-the-road driving test. Hum Psychopharmacol 29: 19-24.
11. Verster JC, Volkerts ER, Schreuder AHCML, et al,. 2002. Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions and psychomotor performance. J Clin Psychopharmacol 22: 576-583.
12. Verster JC, Veldhuijzen DS, Volkerts ER,. 2004. Residual effects of sleep medication on driving ability. Sleep Med Rev 8: 309-325.
13. Verster JC, Bekker EM, De Roos M, et al,. 2008. Methylphenidate significantly improves driving ability of adults with attention-deficit hyperactivity disorder: a randomized crossover trial. J Psychopharmacol 22: 230-239.
14. Verster JC, Bervoets AC, de Klerk S, Roth T,. 2014. Lapses of attention as outcome measure of the on-the-road driving test. Psychopharmacology (Berl) 231: 283-292.
15. Volkerts ER, de Vries G, Meijer T, O'Hanlon JF,. 1984a. Driving performance the day after use of loprazolam, flunitrazepam and placebo. Traffic Research Centre, University of Groningen, The Netherlands. VK 83-04.
16. Volkerts ER, Louwerens JW, Gloerich ABM, et al,. 1984b. Zopiclone's residual effect upon actual driving performance versus those of nitrazepam and flunitrazepam. VSC, Report 84-10, Traffic Research Centre, Groningen, The Netherlands.
17. Volkerts ER, Abbink F, van Laar MW, Plomp TA,. 1989. A Double-blind Study to Compare the Acute Residual Effects of Lormetazepam 1 mg, Oxazepam 50 mg and Placebo on Driving Performance in an Over-the-road Driving Test. NIDDR, University of Utrecht: The Netherlands.
18. Volkerts ER, van Laar MW, van Willigenburg APP, Maes RAA,. 1992. A comparative study of on-the-road and simulated driving performance after nocturnal treatment with lormetazepam 1 mg and oxazepam 50 mg. Hum Psychopharmacol 7: 297-309.